In a groundbreaking clinical trial, immunotherapy alone eliminated rectal cancer in all 14 participants. This study, the ...

Cofactor Genomics announced today OncoPrism for colorectal, breast, bladder, and kidney cancer. This announcement follows ...

John Kopchick, Ph.D., Goll-Ohio Eminent Scholar, was awarded $2.35 million in federal funding to acquire state-of-the-art ...

Reported positive six-month data from ADVANCED-2 trial of TARA-002 in patients with NMIBC; Announcement of initial data from ...

Gallbladder cancer, a highly aggressive disease, often goes undiagnosed until advanced stages due to nonspecific symptoms and ...

First patient enrolled in the Phase II panSOHO basket trial; this is the third BAY 2927088 clinical trial in patients with HER2- activating mutations ...

DelveInsight’s, “Gastric Cancer Pipeline Insight” report provides comprehensive insights about 200+ companies and 220+ ...

Tumor markers may provide valuable insight into treatments and other specific information about your cancer. Learn how ...

Tumor marker blood tests serve as a powerful diagnostic tool for many types of cancer. Learn more about how healthcare ...

Cancer therapy has advanced with molecularly targeted approaches and immunotherapy, yet chemotherapy remains essential for ...

The following is a summary of "Senescence-specific molecular subtypes stratify the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer," published in the February ...